Pharma Priorities

Less than 1 min 06/05/21
Author name: John Ross

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part II)

In Part II of Manufacturing Chemist’s roundtable on how CDMOs are responding to pharma’s top priorities in 2021 Britton Jimenez, Metrics Contract Services’ VP of Business Development discusses the strategy behind novel oral solid dosage timelines. “Some things, such as stability, cannot be expedited; but, occasionally, some elements of the timeline can be delivered more quickly if the right resources are there to support that activity.” Read the full article here.


Related Content